Herman G. Sprenger

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas et al. · Clinical Infectious Diseases · 2010 · 411 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy

Nadine G. Pakker, Eugene D.M.B. Kroon, Marijke Roos et al. · AIDS · 1999 · 106 citations

Life Sciences, Immunology, Infectious Diseases +17

Relationship between Progression to AIDS and Thrombophilic Abnormalities in HIV Infection

Willem M. Lijfering, Herman G. Sprenger, Rita R. Georg et al. · Clinical Chemistry · 2008 · 73 citations

Medicine, Hematology, Infectious Diseases +17

Nelfinavir and nevirapine side effects during pregnancy

Sarah Timmermans, C Tempelman, Mieke H. Godfried et al. · AIDS · 2005 · 71 citations

Pharmacy, Obstetrics, Pharmacotherapy +17